Clinical trial
IntraCoronary Abciximab With the ClearWay Catheter To Improve Outcomes With Lysis
NCT00894023 is registered in ClinicalTrials.gov with Gennaro Sardella as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IntraCoronary Abciximab With the ClearWay Catheter To Improve Outcomes With Lysis
- Lead sponsor
- Gennaro Sardella
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2009
- Completion date
- June 30, 2011
- Enrollment
- 150 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction